Clara Campàs-Moya is Managing Partner and co-founder of the venture capital firm Asabys Partners (Barcelona). As investor, she is a board member at Ona Therapeutics, Sidekick Health, Nuage Therapeutics and ALLOX and formerly at Origo Biopharma (exited).
Before founding Asabys, Clara served as Strategy & Development Director at Kern Pharma and as a Managing Director at the biotech Advancell.She received her Doctorate in Pharmacy and a Master's in Pharmacy from the University of Barcelona. Clara has been involved in the entrepreneurial biotech ecosystem of Barcelona, acting as vice-President of CataloniaBIO, member of the Board of Directors of Biocat, and mentoring several life sciences companies in programs such as CaixaImpulse and BStartup. She is currently member of the board of trustees of SpainCap and the Cercle d'Economia.